Account
FDC signs on One Source to handle Enerzal’s digital remit
Mumbai: Homegrown pharma company FDC Ltd on Monday announced the partnership with integrated marketing business impact consultancy One Source for its electrolyte-based energy drink brand, Enerzal.
The mandate will be spearheaded by lead counsel on the account, Akanksha Srivastava, supported by the national team across Mumbai, Delhi, Bangalore, and Hyderabad. Involving brand management across paid, shared and owned platforms, the remit will span digital and content marketing for the Enerzal brand.
Speaking of the partnership, FDC Ltd, deputy general manager – marketing, Anang Basu said, “When we started working on a slew of integrated marketing projects with One Source, I realised their thought process is extremely result-oriented and outcome-oriented. They think integrated and not tools, which means they look at the best way to find an outcome, not a tactic – something that I look forward to continuing as the hallmark of our relationship. At FDC, our focus as game changers is on partnering with other game-changers.”
One Source, co-founder, Srishty Chawla said, “Our focus as a consultancy has always been on doing work that grows brands and bottom lines. More than 70 per cent of our business is referral-based, and we knew this would happen invariably if we stuck with our motto of being a revenue center for our clientele.”
One Source CEO, Sandeep Rao further added, “We are honoured to work with a leading pharma major such as FDC Limited, especially in light of our extensive experience in the healthcare, wellness, and pharma space. In a wellness-focused India, Enerzal trumps all options, and telling that story is going to be our joy and privilege.”
Enerzal is an electrolyte-based source of hydration launched in 2014, that contains no caffeine, preservatives, or artificial sweeteners. The brand recently introduced Enerzal Zero – a specifically designed product for diabetic patients and fitness enthusiasts with zero sugar content.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
